MedTrace Logo

Taste Test of a New Formulation of Sildenafil (Revatio)

NCT00768573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2021-02-01

No results posted yet for this study

Summary

taste of formulation

Conditions

  • None Volunteer

Interventions

DRUG

sildenafil

Oral suspension of sildenafil.

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768573 on ClinicalTrials.gov